Spiral Therapeutics

Spiral Therapeutics To Present At The Barany Society Meeting 2024

SOUTH SAN FRANCISCO, Calif., Aug. 21, 2024 — Spiral Therapeutics, Inc. (Spiral), a pharmaceutical company committed to developing advanced treatments for balance disorders and hearing loss, today announced that Dr. Jeffrey Sharon will present at the Barany Society Meeting 2024, taking place on Monday, August 26, 2024, in Uppsala, Sweden. Dr. Sharon, who serves as the Senior Vice President of Clinical […]

Spiral Therapeutics to Participate at the 2024 Wedbush PacGrow Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Aug. 5, 2024 — Spiral Therapeutics, Inc. (Spiral), a pharmaceutical company dedicated to developing advanced treatments for balance disorders and hearing loss, today announced that it will participate in the 2024 Wedbush PacGrow Healthcare Conference taking place August 13-14, 2024, in New York, NY. Hugo Peris, Spiral’s Founder and CEO, will participate in a panel focused […]

Spiral Therapeutics Announces Poster Presentation at Association for Research in Otolaryngology Annual Meeting

SOUTH SAN FRANCISCO, Calif., Feb. 06, 2023 — Spiral Therapeutics, Inc. (“Spiral”), a clinical-stage company delivering therapies for inner ear disorders, today announced a presentation at the upcoming Association for Research in Otolaryngology (ARO) 46th Annual MidWinter Meeting, to be held February 11-15, 2023 in Orlando, FL. Dr. Isabel Varela-Nieto will present a poster related […]

Spiral Therapeutics to Present at Biotech Showcase 2023

SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 — Spiral Therapeutics, Inc. (“Spiral”), a clinical-stage company delivering therapies for inner ear disorders, today announced that the Company will provide a corporate overview at Biotech Showcase 2023 taking place in San Francisco, California, from January 9-11, 2023. Presenter Hugo Peris, Chief Executive Officer and President of Spiral […]